Thus, we contribute to a model of AD progression whereby amyloid-neuronal hyperactivity interactions facilitate the spread of tau, advancing disease progression and cognitive decline, a process which is exacerbated by seizures (Fig 8). The gene discussed is MAPT; the disease is Alzheimer disease.